Health
Identifying Platinum Chemotherapy Resistance in Patients With Ovarian Cancer – Technology Networks
Researchers have discovered a way to predict which patients with ovarian cancer are resistant to platinum chemotherapy.
Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may be administered early.
Now, researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants